Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Devon Herrick

WSJ: Medicaid’s Autism Scam Problem

Posted on March 10, 2026March 9, 2026 by Devon Herrick

Fraud within the Medicaid program will continue if states blindly pay claims without verifying the services provided. Furthermore, the federal government needs to force states to bear the entire cost of fraud, since states run their own programs. Better yet, provide a block grant where states control the money and do not get additional funds for waste, fraud, and abuse.

+

Have We Changed Our Clocks for the Last Time?

Posted on March 9, 2026March 9, 2026 by Devon Herrick

While everyone agrees that changing our clocks should stop, nobody can agree on whether to make standard time permanent of daylight savings time permanent. A bill in Congress filed in February, the Daylight Act of 2026, would split the difference. It would move standard time forward 30 minutes and make it permanent. That does not sound particularly appealing either.

+

The FDA is Increasingly Skeptical of Therapies for Rare Diseases

Posted on March 7, 2026March 6, 2026 by Devon Herrick

The FDA under Trump has consistently maintained its stated goal of removing bureaucratic obstacles to drug approval. FDA commissioner, Marty Makary, announced steps to speed the approval of new drugs, including allowing one well-designed clinical trial rather than two or more trials to show efficacy. Yet, drug companies continue to claim inconsistent guidelines, endpoints changed and a skeptical agency when it comes to rare disease therapies. Recently drugmakers have complained the FDA moved the goalposts, after agreeing to them. 

+

Donor Organs are Scarce Only Because there is No Free Market for Organ Donations

Posted on March 5, 2026March 4, 2026 by Devon Herrick

According to the United Network for Organ Sharing, there were more than 48,000 transplants in 2024 compared to around 108,000 on transplant waiting lists. The demand for organs far exceeds the supply. The reason organs are scarce is because living people and their family members have little reason to donate knowing there is little in it for them. It seems the only party involved in the organ transplant industry who does not profit from the process is the donor.

+
  • Previous
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 209
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom